barriers to glp-1 medication prescription We're proud share that Joseph Zucchi, PA-C was recently published in The Boston Globe. His letter highlights an important message: medications used for weight management are not cosmetic, and they deserve The GLP-1 Knowledge Gap |

The cytoprotective action of BPC-157 may indicate that it becomes its new mediator, participating in both the cyto-protective response and the adaptive cyto-protective response, acting against exogenous and endogenous irritating factors

Use a buffer Apply moisturizer before or after a retinoid to reduce irritation

Association of glycated proteins with inflammatory proteins and periodontal disease parameters

Limitations: Animal models may not fully translate to humans No standardized human dosing Long-term safety unknown BPC-157 Peptide Therapy Applications in Injury Recovery and Sports Medicine Tendon and Ligament Injuries BPC-157 shows promise in Achilles tendon injuries, rotator cuff tears, ACL/MCL sprains, tennis elbow, and patellar tendonitis

Highly recommended for serious research